Correlation Between Cyclacel Pharmaceuticals and BiOasis Technologies

Can any of the company-specific risk be diversified away by investing in both Cyclacel Pharmaceuticals and BiOasis Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyclacel Pharmaceuticals and BiOasis Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cyclacel Pharmaceuticals and biOasis Technologies, you can compare the effects of market volatilities on Cyclacel Pharmaceuticals and BiOasis Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyclacel Pharmaceuticals with a short position of BiOasis Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyclacel Pharmaceuticals and BiOasis Technologies.

Diversification Opportunities for Cyclacel Pharmaceuticals and BiOasis Technologies

-0.06

Correlation Coefficient

Cyclacel Pharmaceuticals  BiOasis Technologies

Good diversification

The 3 months correlation between Cyclacel and BiOasis is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Cyclacel Pharmaceuticals and biOasis Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on biOasis Technologies and Cyclacel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyclacel Pharmaceuticals are associated (or correlated) with BiOasis Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of biOasis Technologies has no effect on the direction of Cyclacel Pharmaceuticals i.e., Cyclacel Pharmaceuticals and BiOasis Technologies go up and down completely randomly.

Pair Corralation between Cyclacel Pharmaceuticals and BiOasis Technologies

Given the investment horizon of 90 days Cyclacel Pharmaceuticals is expected to under-perform the BiOasis Technologies. But the stock apears to be less risky and, when comparing its historical volatility, Cyclacel Pharmaceuticals is 1.36 times less risky than BiOasis Technologies. The stock trades about -0.08 of its potential returns per unit of risk. The biOasis Technologies is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  0.01  in biOasis Technologies on October 7, 2024 and sell it today you would earn a total of  0.01  from holding biOasis Technologies or generate 100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Cyclacel Pharmaceuticals  vs.  biOasis Technologies

Cyclacel Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cyclacel Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

biOasis Technologies

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in biOasis Technologies are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, BiOasis Technologies reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cyclacel Pharmaceuticals and BiOasis Technologies

The main advantage of trading using opposite Cyclacel Pharmaceuticals and BiOasis Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyclacel Pharmaceuticals position performs unexpectedly, BiOasis Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BiOasis Technologies will offset losses from the drop in BiOasis Technologies' long position.

The idea behind Cyclacel Pharmaceuticals and biOasis Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.